O

Owkin

Application

French AI company using ML for drug discovery and medical research.

Spun out: Waiv (2026)

Total funding$304.1M

Valuation—

Employees500

Founded2016

HeadquartersParis, France

StatusPrivate

Products

Selected offerings — the AI products recorded here, not the vendor's full catalogue.

• K Pro AI agent Sold on its own

  Research agent that answers biomedical questions across Owkin's clinical and molecular datasets.

• BiomarkerPlus Data service Sold on its own

  Multimodal AI-derived spatial biomarkers, developed with pharmaceutical partners to inform drug discovery and patient stratification.

Similar products 8

No sourced competitor yet: no filing, vendor document or measured-market report read so far names a rival for this company, so none is asserted. The companies below are the closest by what their products do.

How this list is ranked ↗

IMInsilico MedicinePublic · $4.3BBiomarkerPlus and inClinico do comparable work on drug discovery; similar scale (public); ships application, hardware and 1 more rather than the same layer.3 of 3 capabilitiesDifferent layerCompareCDChai DiscoveryPrivate · $3.8BBiomarkerPlus and Chai Discovery platform do comparable work on drug discovery; similar scale (private); ships platform rather than the same layer.1 of 3 capabilitiesDifferent layerCompareCCradlePrivate · $103M raisedBiomarkerPlus and Cradle do comparable work on drug discovery; ships platform rather than the same layer.1 of 3 capabilitiesDifferent layerSame scale bandCompareILIsomorphic LabsPrivate · $2.7B raisedBiomarkerPlus and Drug Design Engine do comparable work on drug discovery; similar scale (private); ships platform rather than the same layer.1 of 3 capabilitiesDifferent layerCompareRPRecursion PharmaceuticalsPublic · $1.9BBiomarkerPlus and Recursion OS do comparable work on drug discovery; similar scale (public); ships platform rather than the same layer.1 of 3 capabilitiesDifferent layerCompareGDGoogle DeepMindAcquiredBiomarkerPlus and AlphaFold Server do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; ships application rather than the same layer.1 of 3 capabilitiesDifferent layerCompareTATempus AIPublic · $12.4BBiomarkerPlus and Tempus Lens do comparable work on drug discovery; similar scale (public); ships agent platform and application rather than the same layer.2 of 3 capabilitiesDifferent layerCompareHCHuawei CloudPrivateBiomarkerPlus and EIHealth do comparable work on drug discovery; Huawei Cloud's scale not recorded; ships API service, application and 4 more rather than the same layer.3 of 3 capabilitiesDifferent layerCompare

Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.

Sources

Total funding

Company disclosure · 27 Aug 2026

"Owkin has raised $304.1m USD from investors..." — Owkin's own press-kit FAQ page, read 2026-08-27.

Employees

News reporting · Mar 2026

Forbes company profile for Owkin, "Employees" stated as of March 2026. Read 2026-08-27.

Founded

Wikipedia · 11 Sep 2026

Infobox: "Founded on August 3, 2016."

Open Owkin in the directory

Something wrong here? Send a correction — quote this company id: owkin.